thymidine has been researched along with u-50488 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barg, J; Levy, R; Nah, SY; Saya, D; Vogel, Z | 1 |
| Barke, RA; Loh, HH; Roy, S | 1 |
2 other study(ies) available for thymidine and u-50488
| Article | Year |
|---|---|
Modulation of thymidine incorporation by kappa-opioid ligands in rat spinal cord-dorsal root ganglion co-cultures.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics; Animals; Benzeneacetamides; Benzomorphans; Cell Communication; Cells, Cultured; Cytosol; DNA; Dose-Response Relationship, Drug; Embryo, Mammalian; Ganglia, Spinal; Inositol Phosphates; Kinetics; Lithium Chloride; Neurons; Pertussis Toxin; Pyrrolidines; Rats; Receptors, Opioid, kappa; Spinal Cord; Thymidine; Time Factors; Tritium; Virulence Factors, Bordetella | 1993 |
MU-opioid receptor-knockout mice: role of mu-opioid receptor in morphine mediated immune functions.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Binding, Competitive; Disease Models, Animal; Drug Implants; Exons; Gene Targeting; Immune System; Immunosuppression Therapy; Interleukin-2; Ligands; Macrophage Activation; Macrophages, Peritoneal; Mice; Mice, Knockout; Mitogens; Morphine; Naltrexone; Organ Size; Phagocytosis; Receptors, Opioid, mu; Spleen; Substance-Related Disorders; Thymidine; Thymus Gland; Tumor Necrosis Factor-alpha | 1998 |